Journal
DRUG DISCOVERY TODAY
Volume 6, Issue 1, Pages 21-26Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1359-6446(00)01611-1
Keywords
-
Categories
Ask authors/readers for more resources
Those following the financial markets and the valuation of biotechnology companies recently might find themselves perplexed. Towards the end of 1999, during which the availability of capital for biotech initial public offerings and for private investment rounds seemingly withered, the markets suddenly turned around and gave the biotechnology industry its biggest bonanza ever.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available